Style | Citing Format |
---|---|
MLA | Motlagh FM, et al.. "Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study." Cardiovascular and Hematological Disorders - Drug Targets, vol. 22, no. 2, 2022, pp. 128-142. |
APA | Motlagh FM, Soleimanpourlichaei HR, Emami A, Kadkhoda S, Shamsara M, Rasti A, Modarressi MH (2022). Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study. Cardiovascular and Hematological Disorders - Drug Targets, 22(2), 128-142. |
Chicago | Motlagh FM, Soleimanpourlichaei HR, Emami A, Kadkhoda S, Shamsara M, Rasti A, Modarressi MH. "Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study." Cardiovascular and Hematological Disorders - Drug Targets 22, no. 2 (2022): 128-142. |
Harvard | Motlagh FM et al. (2022) 'Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study', Cardiovascular and Hematological Disorders - Drug Targets, 22(2), pp. 128-142. |
Vancouver | Motlagh FM, Soleimanpourlichaei HR, Emami A, Kadkhoda S, Shamsara M, Rasti A, et al.. Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study. Cardiovascular and Hematological Disorders - Drug Targets. 2022;22(2):128-142. |
BibTex | @article{ author = {Motlagh FM and Soleimanpourlichaei HR and Emami A and Kadkhoda S and Shamsara M and Rasti A and Modarressi MH}, title = {Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study}, journal = {Cardiovascular and Hematological Disorders - Drug Targets}, volume = {22}, number = {2}, pages = {128-142}, year = {2022} } |
RIS | TY - JOUR AU - Motlagh FM AU - Soleimanpourlichaei HR AU - Emami A AU - Kadkhoda S AU - Shamsara M AU - Rasti A AU - Modarressi MH TI - Bcl11a and the Correlated Key Genes Ascribable to Globin Switching: An In-Silico Study JO - Cardiovascular and Hematological Disorders - Drug Targets VL - 22 IS - 2 SP - 128 EP - 142 PY - 2022 ER - |